PT-141 Research Compound (PT)

"Premium grade PT-141 validation."

PT-141 (Bremelanotide) is a synthetic cyclic heptapeptide with the sequence Ac-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-NH2, a non-selective melanocortin receptor agonist with activity at MC3R and MC4R. It was characterized in clinical research for effects mediated by central melanocortin pathways (Kingsberg et al., Obstet Gynecol 2019, PMID 31599840). PT-141 research peptide is supplied lyophilized at ≥99% purity verified by HPLC, with identity confirmed by mass spectrometry and a batch-specific Certificate of Analysis (COA) included. Store lyophilized powder at −20 °C, protected from light and moisture. For laboratory research use only — not for human or animal consumption.